Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-04-14
Original SEC Filing: Click here

---

Webplus: SVA/20160414/6-K/2_EX-99.1/000.htm SEC Original: v436960_ex99-1.htm
Sinovac Special Committee Engages Financial and Legal Advisors BEIJING, April 14, 2016 — Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the independent special committee of the Company’s Board of Directors, formed to consider “going private” proposals received by the Company, has appointed yesterday Duff & Phelps (Duff &

---

---

Webplus: SVA/20160414/6-K/1/000.htm SEC Original: v436960_6k.htm
FORM 6-K ————– ———- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v436960_6k.htm FORM 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-04-14CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085